Zoghbi Huda Y
Insider CIK 1681643 · REGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2026-08-10 | 2026-08-12 | 800 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-08-10 | 2026-08-12 | 800 | $800.00 | $640.0K | 1,703 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2026-08-10 | 2026-08-12 | 800 | $376.69 | $301.4K | 2,503 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2026-08-10 | 2026-08-12 | 800 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-08-10 | 2026-08-12 | 800 | $800.00 | $640.0K | 1,703 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2026-08-10 | 2026-08-12 | 800 | $376.69 | $301.4K | 2,503 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2026-02-19 | 2026-02-23 | 1,638 | — | $0 | 800 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-02-19 | 2026-02-23 | 50 | $775.50 | $38.8K | 3,242 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-02-19 | 2026-02-23 | 53 | $778.47 | $41.3K | 3,189 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-02-19 | 2026-02-23 | 208 | $779.55 | $162.1K | 2,981 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-02-19 | 2026-02-23 | 331 | $780.45 | $258.3K | 2,650 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-02-19 | 2026-02-23 | 209 | $781.28 | $163.3K | 2,441 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-02-19 | 2026-02-23 | 298 | $782.10 | $233.1K | 2,143 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-02-19 | 2026-02-23 | 220 | $783.29 | $172.3K | 1,923 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-02-19 | 2026-02-23 | 49 | $774.68 | $38.0K | 3,292 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-02-19 | 2026-02-23 | 56 | $785.61 | $44.0K | 1,707 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2026-02-19 | 2026-02-23 | 1,638 | $376.69 | $617.0K | 3,341 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-02-19 | 2026-02-23 | 160 | $784.45 | $125.5K | 1,763 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2026-02-19 | 2026-02-23 | 4 | $790.00 | $3.2K | 1,703 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2026-01-02 | 2026-01-06 | 1,962 | — | $0 | 1,962 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2026-01-02 | 2026-01-06 | 155 | — | $0 | 1,703 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2025-01-02 | 2025-01-06 | 1,958 | — | $0 | 1,958 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2025-01-02 | 2025-01-06 | 166 | — | $0 | 1,548 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2024-01-02 | 2024-01-04 | 1,607 | — | $0 | 1,607 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-01-02 | 2024-01-04 | 1,117 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2024-01-02 | 2024-01-04 | 135 | — | $0 | 1,382 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-01-02 | 2024-01-04 | 1,117 | $900.00 | $1.01M | 1,247 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-01-02 | 2024-01-04 | 1,117 | $391.92 | $437.8K | 2,364 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-10-13 | 2023-10-17 | 1,000 | — | $0 | 1,117 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-10-13 | 2023-10-17 | 1,000 | $391.92 | $391.9K | 2,247 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-10-13 | 2023-10-17 | 1,000 | $850.00 | $850.0K | 1,247 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2023-01-03 | 2023-01-05 | 1,929 | — | $0 | 1,929 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2023-01-03 | 2023-01-05 | 165 | — | $0 | 1,247 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-03-16 | 2022-03-18 | 2,000 | — | $0 | 2,117 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-03-16 | 2022-03-18 | 2,000 | $391.92 | $783.8K | 3,082 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-03-16 | 2022-03-18 | 2,000 | $675.00 | $1.35M | 1,082 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2022-01-03 | 2022-01-05 | 2,707 | — | $0 | 2,707 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2022-01-03 | 2022-01-05 | 191 | — | $0 | 1,082 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-09-14 | 2021-09-15 | 998 | — | $0 | 4,117 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-09-14 | 2021-09-15 | 998 | $391.92 | $391.1K | 1,889 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-14 | 2021-09-15 | 998 | $650.00 | $648.7K | 891 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-09-13 | 2021-09-15 | 2 | — | $0 | 5,115 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-09-13 | 2021-09-15 | 2 | $391.92 | $784 | 893 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-09-13 | 2021-09-15 | 2 | $651.10 | $1.3K | 891 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2021-01-04 | 2021-01-05 | 3,613 | — | $0 | 3,613 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2021-01-04 | 2021-01-05 | 248 | — | $0 | 891 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-07-07 | 2020-07-08 | 1,706 | — | $0 | 5,117 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-07-07 | 2020-07-08 | 1,706 | $391.92 | $668.6K | 2,349 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-07-07 | 2020-07-08 | 1,706 | $650.00 | $1.11M | 643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-06-11 | 2020-06-12 | 1,706 | — | $0 | 6,823 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-06-11 | 2020-06-12 | 1,706 | $391.92 | $668.6K | 2,349 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-11 | 2020-06-12 | 1,706 | $625.00 | $1.07M | 643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-06-10 | 2020-06-12 | 1,706 | — | $0 | 8,529 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-10 | 2020-06-12 | 5 | $613.03 | $3.1K | 822 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-10 | 2020-06-12 | 265 | $612.52 | $162.3K | 827 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-10 | 2020-06-12 | 164 | $611.46 | $100.3K | 1,092 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-10 | 2020-06-12 | 202 | $610.41 | $123.3K | 1,256 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-10 | 2020-06-12 | 161 | $609.48 | $98.1K | 1,458 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-10 | 2020-06-12 | 330 | $608.62 | $200.8K | 1,619 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-10 | 2020-06-12 | 251 | $607.64 | $152.5K | 1,949 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-10 | 2020-06-12 | 80 | $615.28 | $49.2K | 742 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-10 | 2020-06-12 | 99 | $616.19 | $61.0K | 643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-06-10 | 2020-06-12 | 149 | $606.64 | $90.4K | 2,200 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-06-10 | 2020-06-12 | 1,706 | $391.92 | $668.6K | 2,349 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-05-07 | 2020-05-08 | 5,118 | — | $0 | 10,235 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 646 | $567.58 | $366.7K | 1,265 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 1,722 | $565.64 | $974.0K | 4,039 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-05-07 | 2020-05-08 | 5,118 | $391.92 | $2.01M | 5,761 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 609 | $568.37 | $346.1K | 656 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 13 | $569.20 | $7.4K | 643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 2,128 | $566.37 | $1.21M | 1,911 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2020-01-02 | 2020-01-06 | 4,361 | — | $0 | 4,361 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2020-01-02 | 2020-01-06 | 320 | — | $0 | 643 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2019-01-02 | 2019-01-04 | 3,784 | — | $0 | 3,784 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award | 2019-01-02 | 2019-01-04 | 323 | — | $0 | 323 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2018-01-02 | 2018-01-03 | 7,439 | — | $0 | 7,439 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2017-01-03 | 2017-01-04 | 2,438 | — | $0 | 2,438 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2016-09-09 | 2016-09-12 | 15,353 | — | $0 | 15,353 | SEC↗ |